NCT06440850
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Clinical trial condition
Thyroid Gland Oncocytic Carcinoma
Explore clinical trials studying Thyroid Gland Oncocytic Carcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Thyroid Gland Oncocytic Carcinoma trial results
NCT00381641
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +37 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
Active, Not Recruiting
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
NCT03914300
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States